Alto Neuroscience ANRO
NYSE ANRO
$24.81 -0.51 (-2.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alto Neuroscience (ANRO) Other Non Operating Income (2023 - 2026)

Updated

Alto Neuroscience (ANRO) posted Other Non Operating Income of $130,000 for Q2 2026, up 113.1% from $61,000 a year earlier and up 13.0% from the prior quarter.

Analysis

Alto Neuroscience (ANRO) Other Non Operating Income (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Other Non Operating Income at Alto Neuroscience was $357,000; for FY2025, it was -$681,000.

  • In prior years, Alto Neuroscience's Other Non Operating Income was $297,000 in FY2024 and -$525,000 in FY2023.
  • The Q2 2026 figure stands as the highest quarterly Other Non Operating Income since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Alto Neuroscience 870.68 Mn 870.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 130,000.00
Mar 31, 2026 115,000.00
Sep 30, 2025 112,000.00
Jun 30, 2025 61,000.00
Mar 31, 2025 -681,000.00
Dec 31, 2024 6,000.00
Sep 30, 2024 48,000.00
Mar 31, 2024 243,000.00
Dec 31, 2023 -166,000.00
Sep 30, 2023 -226,000.00
Jun 30, 2023 -122,000.00
Mar 31, 2023 -11,000.00
API Access

Alto Neuroscience Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=ANRO&period=max&api_key=YOUR_API_KEY